The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCURAY INC | COM | 004397105 | 1,902 | 674,300 | SH | SOLE | 674,300 | 0 | 0 | ||
ACHILLION PHARMACEUTICALS | COM | 00448Q201 | 2,646 | 438,884 | SH | SOLE | 438,884 | 0 | 0 | ||
ADVAXIS INC | COM NEW | 007624307 | 300 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 6,474 | 267,839 | SH | SOLE | 267,839 | 0 | 0 | ||
AFFIMED NV | COM | N01045108 | 3,106 | 1,133,559 | SH | SOLE | 1,133,559 | 0 | 0 | ||
AKEBIA THERAPEUTICS INC | COM | 00972D105 | 4,870 | 770,538 | SH | SOLE | 770,538 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 2,498 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 1,245 | 40,657 | SH | SOLE | 40,657 | 0 | 0 | ||
APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 1,624 | 359,190 | SH | SOLE | 359,190 | 0 | 0 | ||
ARCTURUS THERAPEUTICS HLDG I | COM | 03969T109 | 1,890 | 173,914 | SH | SOLE | 173,914 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 1,500 | 199,850 | SH | SOLE | 199,850 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 4,494 | 98,942 | SH | SOLE | 98,942 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 975 | 6,071 | SH | SOLE | 6,071 | 0 | 0 | ||
ARQULE INC | COM | 04269E107 | 9,935 | 497,762 | SH | SOLE | 497,762 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 3,909 | 28,100 | SH | SOLE | 28,100 | 0 | 0 | ||
ASLAN PHARMACEUTICALS LTD | ADS | 04522R101 | 239 | 117,682 | SH | SOLE | 117,682 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 728 | 35,573 | SH | SOLE | 35,573 | 0 | 0 | ||
ATRICURE INC | COM | 04963C209 | 10,362 | 318,729 | SH | SOLE | 318,729 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 1,320 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 1,773 | 514,051 | SH | SOLE | 514,051 | 0 | 0 | ||
BIOHAVEN PHARMACEUTICALS HOLD | COM | G11196105 | 4,067 | 74,700 | SH | SOLE | 74,700 | 0 | 0 | ||
BIOTELEMETRY INC | COM | 090672106 | 2,560 | 55,300 | SH | SOLE | 55,300 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 2,238 | 25,500 | SH | SOLE | 25,500 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 9,871 | 123,218 | SH | SOLE | 123,218 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 5,293 | 328,533 | SH | SOLE | 328,533 | 0 | 0 | ||
CARDIOVASCULAR SYSTEMS INC | COM | 141619106 | 2,245 | 46,200 | SH | SOLE | 46,200 | 0 | 0 | ||
CORBUS PHARMACEUTICALS HLDGS | COM | 21833P103 | 1,623 | 297,300 | SH | SOLE | 297,300 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 4,443 | 418,727 | SH | SOLE | 418,727 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 831 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 7,949 | 36,338 | SH | SOLE | 36,338 | 0 | 0 | ||
DEXCOM INC | NOTE 0.750% 5/1 | 252131AF4 | 556 | 250,000 | PRN | SOLE | 250,000 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 2,606 | 118,314 | SH | SOLE | 118,314 | 0 | 0 | ||
ELOXX PHARMACEUTICALS INC | COM | 29014R103 | 1,515 | 205,825 | SH | SOLE | 205,825 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 1,673 | 68,000 | SH | SOLE | 68,000 | 0 | 0 | ||
EVELO BIOSCIENCES INC | COM | 299734103 | 44 | 10,726 | SH | SOLE | 10,726 | 0 | 0 | ||
EXICURE INC | COM | 30205M101 | 787 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 9,198 | 470,000 | SH | SOLE | 470,000 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 9,721 | 47,000 | SH | SOLE | 47,000 | 0 | 0 | ||
GAMIDA CELL LTD | SHS | M47364100 | 640 | 148,781 | SH | SOLE | 148,781 | 0 | 0 | ||
GENOCEA BIOSCIENCES INC | COM NEW | 372427401 | 1,123 | 542,564 | SH | SOLE | 542,564 | 0 | 0 | ||
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 449 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
INOGEN INC | COM | 45780L104 | 1,572 | 23,000 | SH | SOLE | 23,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 716 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
ISHARES TR NASDAQ BIOTECH | ETF | 464287556 | 7,821 | 64,900 | SH | SOLE | 64,900 | 0 | 0 | ||
JOHNSON AND JOHNSON | COM | 478160104 | 1,371 | 9,400 | SH | SOLE | 9,400 | 0 | 0 | ||
KADMON HOLDINGS INC | COM | 48283N106 | 1,696 | 374,423 | SH | SOLE | 374,423 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 440 | 24,725 | SH | SOLE | 24,725 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 2,385 | 173,475 | SH | SOLE | 173,475 | 0 | 0 | ||
LINEAGE CELL THERAPEUTICS IN | COM | 53566P109 | 85 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
LUMINEX CORP | COM | 55027E102 | 4,727 | 204,091 | SH | SOLE | 204,091 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 1,632 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 1,239 | 13,600 | SH | SOLE | 13,600 | 0 | 0 | ||
MASIMO CORPORATION | COM | 574795100 | 474 | 3,000 | SH | SOLE | 3,000 | 0 | 0 | ||
MENLO THERAPEUTICS INC | COM | 586858102 | 3,701 | 797,565 | SH | SOLE | 797,565 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 621 | 108,463 | SH | SOLE | 108,463 | 0 | 0 | ||
MILLENDO THERAPEUTICS INC | COM | 60040X103 | 873 | 129,525 | SH | SOLE | 129,525 | 0 | 0 | ||
MORPHIC HOLDING INC | COM | 61775R105 | 635 | 37,000 | SH | SOLE | 37,000 | 0 | 0 | ||
NATUS MEDICAL INC | COM | 639050103 | 1,415 | 42,900 | SH | SOLE | 42,900 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 6,558 | 61,008 | SH | SOLE | 61,008 | 0 | 0 | ||
NEURONETICS INC | COM | 64131A105 | 1,777 | 395,772 | SH | SOLE | 395,772 | 0 | 0 | ||
NEXTCURE INC | COM | 65343E108 | 1,127 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
OTONOMY INC | COM | 68906L105 | 1,797 | 469,135 | SH | SOLE | 469,135 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 2,203 | 360,542 | SH | SOLE | 360,542 | 0 | 0 | ||
PREVAIL THERAPEUTICS INC | COM | 74140Y101 | 1,187 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
PROQR THERAPEUTICS N V | SHS EURO | N71542109 | 11,040 | 1,114,000 | SH | SOLE | 1,114,000 | 0 | 0 | ||
RADIUS HEALTH INC | COM NEW | 750469207 | 444 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | ||
RADIUS HEALTH INC | NOTE 3.000% 9/0 | 750469AA6 | 3,395 | 4,000,000 | PRN | SOLE | 4,000,000 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 337 | 157,700 | SH | SOLE | 157,700 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 9,010 | 124,806 | SH | SOLE | 124,806 | 0 | 0 | ||
SCYNEXIS INC | COM | 811292101 | 1,099 | 1,207,413 | SH | SOLE | 1,207,413 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 72,370 | 13,680,554 | SH | SOLE | 13,680,554 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 440 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
SYNLOGIC INC | COM | 87166L100 | 1,292 | 500,731 | SH | SOLE | 500,731 | 0 | 0 | ||
TRANSLATE BIO INC | COM | 89374L104 | 1,464 | 179,845 | SH | SOLE | 179,845 | 0 | 0 | ||
TURNING POINT THERAPEUTICS I | COM | 90041T108 | 1,894 | 30,408 | SH | SOLE | 30,408 | 0 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 133 | 3,987 | SH | SOLE | 3,987 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 1,678 | 209,200 | SH | SOLE | 209,200 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 296 | 36,960 | SH | SOLE | 36,960 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 3,262 | 248,854 | SH | SOLE | 248,854 | 0 | 0 | ||
ZAFGEN INC | COM | 98885E103 | 339 | 305,500 | SH | SOLE | 305,500 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 5,565 | 106,749 | SH | SOLE | 106,749 | 0 | 0 |